Fabian Zech

1.5k total citations · 1 hit paper
18 papers, 283 citations indexed

About

Fabian Zech is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Fabian Zech has authored 18 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Fabian Zech's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (8 papers) and interferon and immune responses (3 papers). Fabian Zech is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (8 papers) and interferon and immune responses (3 papers). Fabian Zech collaborates with scholars based in Germany, United States and Slovakia. Fabian Zech's co-authors include Frank Kirchhoff, Konstantin M. J. Sparrer, Timo Jacob, Christoph Jung, Dorota Kmieć, Lennart Koepke, Theo Sanderson, Rayhane Nchioua, Alexander Graf and Caterina Prelli Bozzo and has published in prestigious journals such as The Journal of Physical Chemistry B, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Fabian Zech

17 papers receiving 280 citations

Hit Papers

Omicron: What Makes the Latest SARS-CoV-2 Variant of Conc... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabian Zech Germany 7 241 72 47 31 26 18 283
Pan-Pan Zhou China 8 252 1.0× 91 1.3× 47 1.0× 34 1.1× 16 0.6× 12 327
Yanjia Chen China 4 286 1.2× 92 1.3× 26 0.6× 24 0.8× 23 0.9× 7 320
Irene P. Chen United States 8 226 0.9× 129 1.8× 38 0.8× 37 1.2× 22 0.8× 10 327
Ziteng Liang China 7 325 1.3× 80 1.1× 28 0.6× 30 1.0× 21 0.8× 17 362
Kaitlin R. Sprouse United States 6 295 1.2× 99 1.4× 30 0.6× 17 0.5× 18 0.7× 8 310
Elaine C. Chen United States 5 215 0.9× 71 1.0× 64 1.4× 24 0.8× 11 0.4× 8 278
Danny Noack Netherlands 7 205 0.9× 58 0.8× 22 0.5× 50 1.6× 20 0.8× 12 283
Mingru Liu United States 5 312 1.3× 91 1.3× 36 0.8× 16 0.5× 15 0.6× 9 335
Belinda M. Dcosta United States 10 375 1.6× 105 1.5× 28 0.6× 20 0.6× 18 0.7× 11 402
Christiane Pallas Germany 6 339 1.4× 102 1.4× 28 0.6× 29 0.9× 20 0.8× 10 371

Countries citing papers authored by Fabian Zech

Since Specialization
Citations

This map shows the geographic impact of Fabian Zech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Zech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Zech more than expected).

Fields of papers citing papers by Fabian Zech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Zech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Zech. The network helps show where Fabian Zech may publish in the future.

Co-authorship network of co-authors of Fabian Zech

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Zech. A scholar is included among the top collaborators of Fabian Zech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Zech. Fabian Zech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zech, Fabian, Christoph Jung, Armando Rodríguez, et al.. (2025). ReaxFF-Guided Optimization of VIRIP-Based HIV-1 Entry Inhibitors. The Journal of Physical Chemistry B. 129(15). 3788–3795. 1 indexed citations
2.
Fresco‐Cala, Beatriz, et al.. (2025). Dual surrogate imprinting: an innovative strategy for the preparation of virus-selective particles. Materials Horizons. 12(5). 1486–1493. 1 indexed citations
3.
Zech, Fabian, et al.. (2025). Interactions of Peptide Amphiphiles With Viruses and Cells Are Enabled by Amorphous Nanostructures. Journal of Peptide Science. 31(9). e70051–e70051. 1 indexed citations
4.
Zech, Fabian, Rayhane Nchioua, Christoph Jung, et al.. (2025). Role of N-linked glycosylation sites in human ACE2 in SARS-CoV-2 and hCoV-NL63 infection. Journal of Virology. 99(5). e0220224–e0220224.
5.
Volčič, Meta, Rayhane Nchioua, Fabian Zech, et al.. (2024). Attenuated replication and damaging effects of SARS‐CoV‐2 Omicron variants in an intestinal epithelial barrier model. Journal of Medical Virology. 96(7). e29783–e29783. 4 indexed citations
6.
Bozzo, Caterina Prelli, Dorota Kmieć, Rayhane Nchioua, et al.. (2023). Endogenous IFITMs boost SARS-coronavirus 1 and 2 replication whereas overexpression inhibits infection by relocalizing ACE2. iScience. 26(4). 106395–106395. 9 indexed citations
7.
Wang, Qingxing, Alina Seidel, Janis A. Müller, et al.. (2023). Determinants of species-specific utilization of ACE2 by human and animal coronaviruses. Communications Biology. 6(1). 1051–1051. 8 indexed citations
8.
Nchioua, Rayhane, Susanne Klute, Lennart Koepke, et al.. (2023). Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1. Life Science Alliance. 6(6). e202201745–e202201745. 12 indexed citations
9.
Nchioua, Rayhane, et al.. (2023). Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization. iScience. 26(11). 108299–108299. 5 indexed citations
10.
Zech, Fabian, Mirja Harms, Jan Münch, et al.. (2023). Peptide Bispecifics Inhibiting HIV-1 Infection by an Orthogonal Chemical and Supramolecular Strategy. Bioconjugate Chemistry. 34(9). 1645–1652. 4 indexed citations
11.
Schmidt, Hanna, Alexander Sauter, Fabian Zech, et al.. (2022). Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection. American Journal of Physiology-Cell Physiology. 322(4). C591–C604. 3 indexed citations
12.
Zech, Fabian, Tatjana Weil, Alina Seidel, et al.. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses. Clinical Infectious Diseases. 75(1). e653–e661. 14 indexed citations
13.
Harms, Mirja, Manuel Hayn, Fabian Zech, Frank Kirchhoff, & Jan Münch. (2022). Endogenous Peptide Inhibitors of HIV Entry. Advances in experimental medicine and biology. 1366. 65–85. 1 indexed citations
14.
Zech, Fabian, Christoph Jung, Timo Jacob, et al.. (2022). Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2. Cell Host & Microbe. 30(9). 1255–1268.e5. 45 indexed citations
15.
Nchioua, Rayhane, Dorota Kmieć, Caterina Prelli Bozzo, et al.. (2022). SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells. Journal of Virology. 96(11). e0059422–e0059422. 25 indexed citations
16.
Jung, Christoph, Dorota Kmieć, Lennart Koepke, et al.. (2022). Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?. Journal of Virology. 96(6). e0207721–e0207721. 143 indexed citations breakdown →
17.
Zech, Fabian, et al.. (2022). Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron Subvariants BA.1 and BA.2. SSRN Electronic Journal. 1 indexed citations
18.
Zech, Fabian, Maximilian Hirschenberger, Steffen Stenger, et al.. (2022). Near-Native Visualization of SARS-CoV-2 Induced Membrane Remodeling and Virion Morphogenesis. Viruses. 14(12). 2786–2786. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026